100%(1)Il 100% ha trovato utile questo documento (1 voto)
1K visualizzazioni2 pagine
Generic/Brand Name & Classification: Clopidogrel (Plavix), a platelet aggregation inhibitor antiplatelet drug.
Indication & Mechanism of Action: Used to treat patients at risk for ischemic events like heart attack or stroke by inhibiting platelet aggregation and preventing clumping through blocking ADP receptors on platelets.
Adverse Effects: Potential side effects include headache, dizziness, weakness, syncope, flushing, hypertension, edema, rash, pruritus, nausea, GI distress, constipation, diarrhea, and GI bleeding.
Generic/Brand Name & Classification: Clopidogrel (Plavix), a platelet aggregation inhibitor antiplatelet drug.
Indication & Mechanism of Action: Used to treat patients at risk for ischemic events like heart attack or stroke by inhibiting platelet aggregation and preventing clumping through blocking ADP receptors on platelets.
Adverse Effects: Potential side effects include headache, dizziness, weakness, syncope, flushing, hypertension, edema, rash, pruritus, nausea, GI distress, constipation, diarrhea, and GI bleeding.
Generic/Brand Name & Classification: Clopidogrel (Plavix), a platelet aggregation inhibitor antiplatelet drug.
Indication & Mechanism of Action: Used to treat patients at risk for ischemic events like heart attack or stroke by inhibiting platelet aggregation and preventing clumping through blocking ADP receptors on platelets.
Adverse Effects: Potential side effects include headache, dizziness, weakness, syncope, flushing, hypertension, edema, rash, pruritus, nausea, GI distress, constipation, diarrhea, and GI bleeding.
Name & & of Drug Action Effects Drug Responsibilities Teaching
Classification Formulation Interaction Generic: Ordered: Indication: CNS: Headache, Before: - Advise patient dizziness, it may take Clopidogrel 75mg/tab 1 tab - Treatment of patients at weakness, risk for ischemic events longer than OD syncope, flushing usual to stop history of MI, ischemic During: stroke, peripheral artery bleeding. Tell Brand: CV: disease Hypertension, him to refrain Plavix Timing: edema After: from activities - Treatment of patients in which 8am with acute coronary Dermatologic: trauma and syndrome Rash, pruritus bleeding may Classification: occur, and Therapuetic Duration: GI: Nausea, GI Mechanism of action: encourage him 5 days distress, to wear a seat class: constipation, Inhibits platelet belt when in a Antiplatelet diarrhea, GI aggregation by blocking bleed car. Pharmacologic Other forms: ADP receptors on platelets, Other: - Instruct class: Platelet preventing clumping of Increased patient to platelets bleeding risk notify aggregation prescriber if inhibitor unusual bleeding or Pregnancy risk bruising occurs. category B - Tell patient to inform all health care providers, including dentists, before undergoing procedures or starting new drug theraphy, that he is taking drug.
- Inform patient that drug may be taken without regard to meals.